Incyte Corp (MEX:INCY)
MXN 1486 0 (0%) Market Cap: 299.60 Bil Enterprise Value: 264.63 Bil PE Ratio: 541.07 PB Ratio: 4.61 GF Score: 80/100

Incyte Corp at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 14, 2023 / 07:15AM GMT
Release Date Price: MXN1629
Daniel Lundquist

Hello, good morning, and welcome to day 2 of the Bank of America London Healthcare Conference. I'm Dan Lundquist, the U.S. healthcare specialist. I am very pleased to have the management of Incyte with me here on stage to kick us off. We have Herve Hoppenot, Chairman and CEO; as well as Christiana Stamoulis, the Chief Financial Officer. I will join them over here on the fire side.

Questions & Answers

Daniel Lundquist

And just to kick us off, Herve, maybe just kind of give us an update on this year, how things have gone and maybe anything you'd like to give an update on.

Herve Hoppenot
Incyte Corporation - CEO & Chairman

Okay. Yes. Thank you. So this year, I mean it's obviously a year where we continue on two things. I mean it's growth and diversification on the commercial side and obviously with the pipeline. So on the growth side, I mean, the Q2 results were, in fact, very strong in terms of top line growth, both on Jakafi and on the rest of the portfolio. The Jakafi number is showing that, that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot